08 Nov 2024 07:00 CET

Issuer

Omda AS

Oslo, Norway, 08 November 2024: Today, Omda AS (“Omda”), a leading provider of
specialised software for healthcare and emergency response, published its
results for the third quarter of 2024.

Total revenue increased to 103 MNOK, compared to 100 MNOK in Q3-23. The
company’s long-standing customer relationships remain a solid base, with 6%
growth in recurring revenue representing 81% of total sales in Q3-24.

Omda delivered an EBITDA of 22 MNOK for the quarter, resulting in a 21% EBITDA
margin. Gross margin was stable at 93%.

Omda CEO Sverre Flatby is optimistic about the underlying trend: “Recurring
revenues are steadily increasing alongside the implementation of cost reduction
strategies. This combination provides confidence that margin improvements will
continue into 2025.”

In Q3, the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF)
awarded Omda a contract for the implementation of a regional solution for
oncology medication management. The Authority owns eleven health trusts and
provides specialist health services for more than 3 million inhabitants.

Flatby highlights the importance of the contract: “Having earned the trust of
the largest Norwegian health region is a stamp of approval for our solution and
a testament of our leading role as a vendor of mission-critical specialised
software.”

Highlights from the report:
• Q3-24 total income 103 MNOK vs 100 MNOK in Q3-23
• Recurring revenue grew 6% to 83 MNOK and accounted for 81% of total sales
• Reported EBITDA was 22 MNOK resulting in a 21% EBITDA margin
• Q3-24 organic growth of 3% in local currency (4% in NOK)
• Gross margin remained stable at 93% (93%)

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@omda.com

About Omda
Omda is the leading provider of specialised software for healthcare and
emergency services in the Nordics with a growing presence in Europe, North
America and the Pacific region. The company has more than 500 customers in 27
countries and employs more than 250 dedicated specialists. Our highly
specialised healthcare solutions empower medical professionals and emergency
responders, enabling them to know more and work smarter. With a focus on
user-centric design, value-driven development and close working relationships
with customers, Omda delivers solutions that enhance patient safety and improve
healthcare outcomes.

For more information, visit www.omda.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH


631673_Omda Q3 2024 Presentation.pdf
631673_Omda QR Q3 2024.pdf

Source

Omda AS

Provider

Oslo Børs Newspoint

Company Name

Omda AS 23/28 FRN FLOOR C, OMDA AS

ISIN

NO0013075721, NO0010894512

Symbol

OMDA

Market

Nordic Alternative Bond Market Euronext Growth